期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Therapeutic potential of Rho-associated kinase inhibitor Y27632 in corneal endothelial dysfunction:an in vitro and in vivo study
1
作者 Yao-Wen Song Jun-Yu Chen +2 位作者 Xu Li Li Wang Zhi-Qiang Pan 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2021年第1期19-25,共7页
AIM:To investigate the effects of a selective inhibitor of Rho-associated kinase(ROCK),Y-27632,on inbred Wuzhishan porcine corneal endothelial cells(PCECs)in vitro and in vivo studies.METHODS:Primary PCECs were trypsi... AIM:To investigate the effects of a selective inhibitor of Rho-associated kinase(ROCK),Y-27632,on inbred Wuzhishan porcine corneal endothelial cells(PCECs)in vitro and in vivo studies.METHODS:Primary PCECs were trypsinized from Wuzhishan miniature porcine corneal tissues.The optimal concentration of Y-27632 on PCECs was determined through MTT and 5-ethynyl-2'-deoxyuridine(EdU)-labeling assays.Seven New Zealand rabbits were used as a corneal endothelial dysfunction model,and a PCECs suspension supplemented with Y-27632 was injected into the anterior chamber of the rabbits.The progression of rabbit corneal opacity and edema were observed by slit lamp examination.The rabbits were sacrificed,and rabbit globes were enucleated for trypan blue-alizarin red staining,hematoxylineosin staining,and immunofluorescence analysis.RESULTS:Administration of 100μmol/L Y-27632 facilitated PCECs'proliferation obviously.The rabbit corneas injected with PCECs suspension and 100μmol/L Y-27632 were restored to transparency significantly after 14d.CONCLUSION:The 100μmol/L Y-27632 treatment improves PCECs'proliferation significantly.And our results suggest that Y-27632 and PCECs can be used to treat corneal endothelial dysfunction. 展开更多
关键词 corneal endothelial dysfunction Rho kinase inhibitor y-27632 porcine corneal endothelial cells cell proliferation
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部